Cantor Equity Partners IV adds Dr. Mukesh Prasad
Cantor Equity Partners IV, Inc. (symbol CEPF) appointed Dr. Mukesh Prasad to its board of directors effective August 25, 2026.
Rhea-AI Filing Summary
Cantor Equity Partners IV, Inc. (symbol CEPF) appointed Dr. Mukesh Prasad to its board of directors effective August 25, 2026. He will serve as a Class I director and join both the audit committee and the compensation committee.
Dr. Prasad, age 55, is Founder and Co-Managing Partner of Innova Capital Partners and an Otolaryngologist at Weill Cornell Medical College, where he has served as Associate Professor of Clinical Otolaryngology and Head and Neck Surgery since 2002. He has prior board experience with related Cantor investment vehicles. For his board service at Cantor Equity Partners IV, Inc., he will receive $50,000 per year, paid quarterly. The company states there are no family relationships between Dr. Prasad and its directors or executive officers.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Annual director compensation: $50,000 per year
Director age: 55
Share class par value: $0.0001 per share
+2 more
5 metrics
Annual director compensation
$50,000 per year
Compensation approved for Dr. Prasad’s board service, paid quarterly
Director age
55
Age of Dr. Mukesh Prasad at time of appointment
Share class par value
$0.0001 per share
Par value of Class A ordinary shares listed as CEPF on Nasdaq
Innova Capital Partners role start
2014
Year Dr. Prasad began serving as Founder and Co-Managing Partner of Innova
Weill Cornell service start
2002
Year Dr. Prasad began practicing and serving as Associate Professor at Weill Cornell Medical College
Key Terms
Class I director, audit committee, compensation committee, initial business combination, +1 more
5 terms
Class I director regulatory
"Dr. Prasad will serve as a Class I director."
A class I director is a member of a company’s board who belongs to one of several groups whose terms expire in a specified year under a staggered election system; each class is elected on a different cycle so only a portion of the board faces re-election each year. This matters to investors because it affects how quickly control of the board can change, the company’s continuity and oversight, and the ease of mounting or defending against takeover efforts—think of a team where only some players are replaced each season rather than the whole roster at once.
audit committee regulatory
"appointed Dr. Prasad as a member of the audit committee of the Board"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
compensation committee regulatory
"appointed Dr. Prasad as a member of the audit committee of the Board and a member of the compensation committee"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
initial business combination financial
"until consummation of its initial business combination with Securitize, Inc."
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What board change did CEPF announce on August 25, 2026?
Cantor Equity Partners IV, Inc. (CEPF) appointed Dr. Mukesh Prasad as a Class I director effective August 25, 2026, and also named him to its audit committee and compensation committee.
What is Dr. Mukesh Prasad’s compensation as a director of CEPF?
Dr. Mukesh Prasad will receive $50,000 per year for serving on the board of Cantor Equity Partners IV, Inc., with payments made on a quarterly basis.
What relevant experience does Dr. Mukesh Prasad bring to CEPF?
Dr. Prasad has served since 2014 as Founder and Co-Managing Partner of Innova Capital Partners, a private global investment firm, and since 2002 as an Otolaryngologist and Associate Professor at Weill Cornell Medical College, with extensive experience in finance, investing and medicine.
Are there any family relationships between Dr. Prasad and CEPF’s management?
Cantor Equity Partners IV, Inc. states that there are no family relationships between Dr. Mukesh Prasad and any director, executive officer, or person chosen to become an executive officer of the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
